-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $103

Benzinga·05/08/2026 13:30:43
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $104 to $103.